Bayer: to boost Covid-19 analysis capacity in Germany
(CercleFinance.com) - Bayer is boosting its Covid-19 analysis capacity by establishing a two-story testing laboratory at its Berlin campus, the German pharmaceutical and chemical maker said on Monday.
At its Berlin site alone, over 140 employees have volunteered to staff the new facility, which soon should be able to conduct up to 1,000 additional SARS-CoV-2 tests each day, the company said.
Bayer said it is also supplying three certified clinical diagnostic laboratories with company apparatus from its Leverkusen, Monheim, Wuppertal and Cologne plants.
In all, the company will provide over 40 virus diagnostics devices from its research operations, enabling Germany's Covid-19 analysis capacity to be increased by several thousand tests daily, it said.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
At its Berlin site alone, over 140 employees have volunteered to staff the new facility, which soon should be able to conduct up to 1,000 additional SARS-CoV-2 tests each day, the company said.
Bayer said it is also supplying three certified clinical diagnostic laboratories with company apparatus from its Leverkusen, Monheim, Wuppertal and Cologne plants.
In all, the company will provide over 40 virus diagnostics devices from its research operations, enabling Germany's Covid-19 analysis capacity to be increased by several thousand tests daily, it said.
Copyright (c) 2020 CercleFinance.com. All rights reserved.